159 related articles for article (PubMed ID: 18004740)
1. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
[TBL] [Abstract][Full Text] [Related]
2. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
Sheng G; Bernabe KQ; Guo J; Warner BW
Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
[TBL] [Abstract][Full Text] [Related]
4. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
5. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
7. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
8. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells.
Liu ZM; Huang HS
Cell Signal; 2006 Feb; 18(2):244-55. PubMed ID: 15961274
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells.
Han J; Tsukada Y; Hara E; Kitamura N; Tanaka T
J Biol Chem; 2005 Sep; 280(36):31548-56. PubMed ID: 16014626
[TBL] [Abstract][Full Text] [Related]
10. Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation.
Fujino T; Takeuchi A; Maruko-Ohtake A; Ohtake Y; Satoh J; Kobayashi T; Tanaka T; Ito H; Sakamaki R; Kashimura R; Ando K; Nishimaki-Mogami T; Ohkubo Y; Kitamura N; Sato R; Kikugawa K; Hayakawa M
J Biochem; 2012 Dec; 152(6):577-86. PubMed ID: 22969091
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
[TBL] [Abstract][Full Text] [Related]
12. Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells.
Yang H; Magilnick N; Noureddin M; Mato JM; Lu SC
J Cell Physiol; 2007 Mar; 210(3):766-73. PubMed ID: 17154373
[TBL] [Abstract][Full Text] [Related]
13. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation.
Kim SE; Choi KY
Cell Signal; 2007 Jul; 19(7):1554-64. PubMed ID: 17374561
[TBL] [Abstract][Full Text] [Related]
14. Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation.
Kondo A; Hirayama N; Sugito Y; Shono M; Tanaka T; Kitamura N
J Biol Chem; 2008 Jan; 283(3):1428-1436. PubMed ID: 18003605
[TBL] [Abstract][Full Text] [Related]
15. Role of intracellular Ca2+ and calmodulin/MAP kinase kinase/extracellular signal-regulated protein kinase signalling pathway in the mitogenic and antimitogenic effect of nitric oxide in glia- and neurone-derived cell lines.
Meini A; Garcia JB; Pessina GP; Aldinucci C; Frosini M; Palmi M
Eur J Neurosci; 2006 Apr; 23(7):1690-700. PubMed ID: 16623825
[TBL] [Abstract][Full Text] [Related]
16. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
[TBL] [Abstract][Full Text] [Related]
18. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
Tsukada Y; Tanaka T; Miyazawa K; Kitamura N
J Biochem; 2004 Nov; 136(5):701-9. PubMed ID: 15632311
[TBL] [Abstract][Full Text] [Related]
19. Induction of hepatocyte growth factor expression by maleic acid in human fibroblasts through MAPK activation.
Motoki T; Sugiura Y; Matsumoto Y; Tsuji T; Kubota S; Takigawa M; Gohda E
J Cell Biochem; 2008 Jul; 104(4):1465-76. PubMed ID: 18491380
[TBL] [Abstract][Full Text] [Related]
20. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T
Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
